NEW YORK (GenomeWeb) – Thermo Fisher Scientific is in the midst of rolling out a qPCR-based research-use-only multi-target women's health panel based on its TaqMan chemistry and OpenArray architecture, company officials said recently.

The panel will feature assays for 34 total organisms along with controls, and will be primarily for use on the company's QuantStudio 12K Flex instrument. It is currently in the "soft launch" phase but will be fully commercially available by November, company officials said.